Natalia M. V.
- Country
- Spain
- Department
- #3409:Reumatología
Research Overview
- Efficacy and Safety Evaluation of Rapcabtagene Autoleucel Versus Rituximab in Severe Refractory Diffuse Cutaneous Systemic Sclerosis
- Efficacy and Safety Evaluation of KPL-404 in a Phase 2 Randomized, Double-blind, Placebo-controlled Study for Sjögren’s Disease
- Evaluation of Rapcabtagene Autoleucel Versus Standard Treatment in Severe Refractory Idiopathic Inflammatory Myopathies: A Phase 2 Randomized Controlled Trial
Data & Insights
Has run more than one trial at 43 of 125 partner sites.
Specializations
Autoimmune Disorders
This investigator specializes in treating Sjögren's Disease, focusing on innovative therapeutic approaches for managing systemic manifestations of this autoimmune condition.
- Systemic Disease Activity Management
- Novel Treatment Evaluation
Their work encompasses comprehensive assessment of autoimmune manifestations and their impact on patient quality of life.
Connective Tissue Disorders
The investigator has significant expertise in treating connective tissue disease-associated interstitial lung disease (CTD-ILD) and systemic sclerosis.
- Lung Volume Assessment
- Cutaneous Manifestations
- Disease Progression Monitoring
Their research focuses on preventing organ damage and improving outcomes in complex connective tissue disorders.
Inflammatory Conditions
Specializing in severe refractory idiopathic inflammatory myopathies (IIM), the investigator explores advanced therapeutic options for challenging cases.
- Treatment-Resistant Cases
- Improvement Score Assessment
- Innovative Therapy Applications
Their expertise extends to evaluating novel therapeutic approaches for inflammatory conditions that don't respond to conventional treatments.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.